Drugs / PROSPIDIUM
PROSPIDIUM
also known as
Chlorure de prospidium · Cloruro de prospidio · NSC-166100 · Prospidium cation · Prospidium chloride · Prospidium ion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06232434 | Jun → Dec 2025 overdue | gastric cancer | Research Institute for Physical Chemical Problems of the Belarusian State University | Recruiting | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PROSPIDIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL1187562 ↗ |
| Known as | Chlorure de prospidium | ChEMBL registry synonym — accepted as the source's own label CHEMBL1187562 ↗ |
| Known as | Cloruro de prospidio | ChEMBL registry synonym — accepted as the source's own label CHEMBL1187562 ↗ |
| Known as | NSC-166100 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1187562 ↗ |
| Known as | Prospidium cation | ChEMBL registry synonym — accepted as the source's own label CHEMBL1187562 ↗ |
| Known as | Prospidium chloride | “Prospidium chloride (in the form of prospidelong (a mixture of prospidium chloride and dextran sodium salt phosphate containing carbamate groups in a 1:1 ratio)) - 1000 mg.” NCT06232434 ↗ |
| Known as | Prospidium ion | ChEMBL registry synonym — accepted as the source's own label CHEMBL1187562 ↗ |
| Modality | Small molecule | — CHEMBL1187562 ↗ |